搜尋結果
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel
Forbes· 3 日前The panel concluded that the therapeutic is effective in treating the memory-robbing condition ...
Council Post: Employee Health And Wellness Programs Have Overlooked Brain Health: The Case For ...
Forbes· 15 小時前In the fast-paced world of business, where every decision can make or break a company's ...
Inside Samsung’s ‘Solve For Tomorrow’ Competition And How STEM Makes New York City’s Streets ...
Forbes· 7 日前At the end of April, Samsung held the final round of its Solve for Tomorrow STEM competition in ...
Apple Has Created ‘Apple Intelligence’ Unto Its Own Image, Accessibility Included
Forbes· 15 小時前A thought crystallized for me earlier this week as I sat in the audience at downtown San Jose’s ...
A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club
CNBC· 2 日前Eli Lilly became the most valuable health-care company in the world on the back of its ...
Why Aging Parents With Memory Loss Must Stop Managing Money
Forbes· 15 小時前A new study published in the New York Times demonstrates some startling findings about loss of ability to make money decisions ...
Art@Harbour 2024 well received
news.gov.hk· 4 日前The large-scale outdoor art project "Art@Harbour2024" attracted over 2 million visitors, which exceeded the original estimate ...
Big Lots Left With Challenge After Results Show Consumer Squeeze
Forbes· 7 日前Downbeat first quarter results for Big Lots did little to stem the bleed out of stock value ...
The voice behind 600 silent success stories
China Daily· 2 日前Having dedicated over 15 years to assisting hearing-impaired children, Li has helped more than ...
Up Nearly 15% In A Week, Will Illumina Stock Continue To See Higher Levels?
Forbes· 4 日前Illumina stock (NASDAQ: ILMN) saw a 7% rise on Thursday, June 6, faring better than its peer — ...